Discovery of a small molecule targeting autophagy via ATG4B inhibition and cell death of colorectal cancer cells in vitro and in vivo.


Journal

Autophagy
ISSN: 1554-8635
Titre abrégé: Autophagy
Pays: United States
ID NLM: 101265188

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 4 9 2018
medline: 7 3 2020
entrez: 4 9 2018
Statut: ppublish

Résumé

Human Atg4 homologs are cysteine proteases, which play key roles in the macroautophagy/autophagy process by cleaving Atg8 homologs for conjugation to lipid membranes and for deconjugation of Atg8 homologs from membranes. Expression of ATG4B is significantly increased in colorectal cancer cells compared to normal cells, suggesting that ATG4B may be important for cancer biology. Inhibition of ATG4B may reduce the autophagy activity, thereby sensitizing cancer cells to therapeutic agents. Thus, developing specific and potent ATG4B inhibitors for research as well as for potential therapeutic uses is highly needed. In this study, we integrated

Identifiants

pubmed: 30176161
doi: 10.1080/15548627.2018.1517073
pmc: PMC6333450
doi:

Substances chimiques

Autophagy-Related Proteins 0
MAP1LC3A protein, human 0
Microtubule-Associated Proteins 0
Small Molecule Libraries 0
ATG4B protein, human EC 3.4.22.-
Cysteine Endopeptidases EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

295-311

Références

J Clin Invest. 2015 Jan;125(1):14-24
pubmed: 25654546
Eur J Med Chem. 2009 Jun;44(6):2523-32
pubmed: 19243862
Methods Enzymol. 2017;587:207-225
pubmed: 28253956
Autophagy. 2014;10(11):2021-35
pubmed: 25483883
Autophagy. 2012 Feb 1;8(2):177-86
pubmed: 22240591
J Cell Biol. 2000 Oct 16;151(2):263-76
pubmed: 11038174
J Cell Sci. 2004 Jun 1;117(Pt 13):2805-12
pubmed: 15169837
Semin Cancer Biol. 2015 Apr;31:99-105
pubmed: 24933034
Autophagy. 2012 May 1;8(5):780-93
pubmed: 22622160
Cancer Res. 2008 Mar 1;68(5):1485-94
pubmed: 18316613
Cell Res. 2014 Jan;24(1):69-79
pubmed: 24323045
PLoS One. 2013 Sep 10;8(9):e74222
pubmed: 24040206
Clin Cancer Res. 2011 Feb 15;17(4):654-66
pubmed: 21325294
Autophagy. 2014 Aug;10(8):1454-65
pubmed: 24991826
Cell Death Dis. 2016 Aug 11;7(8):e2330
pubmed: 27512951
Annu Rev Cell Dev Biol. 2011;27:107-32
pubmed: 21801009
Autophagy. 2012 Jun;8(6):883-92
pubmed: 22652539
Genes Dev. 2016 Aug 1;30(15):1718-30
pubmed: 27542828
Autophagy. 2012 Mar;8(3):401-12
pubmed: 22302004
J Biol Chem. 2011 Mar 4;286(9):7327-38
pubmed: 21177865
Cancer Lett. 2016 Apr 1;373(1):19-26
pubmed: 26805760
ACS Med Chem Lett. 2016 Jun 25;7(8):802-6
pubmed: 27563406
J Biol Chem. 2004 Aug 27;279(35):36268-76
pubmed: 15187094
J Clin Invest. 2010 Jul;120(7):2273-6
pubmed: 20577044
J Clin Invest. 2010 Jul;120(7):2331-44
pubmed: 20577052
Blood. 2014 Jun 5;123(23):3622-34
pubmed: 24755409
Cell. 2011 Sep 30;147(1):223-34
pubmed: 21962518
J Biol Chem. 2003 Feb 7;278(6):3671-8
pubmed: 12446702
Autophagy. 2007 Sep-Oct;3(5):452-60
pubmed: 17534139
Eur J Med Chem. 2016 Nov 10;123:631-638
pubmed: 27517808
Mol Biol Cell. 2008 Nov;19(11):4651-9
pubmed: 18768752
J Med Chem. 2017 Feb 9;60(3):1225
pubmed: 28118004
EMBO J. 2007 Apr 4;26(7):1749-60
pubmed: 17347651
N Engl J Med. 2013 May 9;368(19):1845-6
pubmed: 23656658
PLoS One. 2015 Apr 20;10(3):e0122083
pubmed: 25894744
Nat Rev Drug Discov. 2017 Jul;16(7):487-511
pubmed: 28529316
Vet Pathol. 2011 Mar;48(2):486-94
pubmed: 20634410
J Biol Chem. 2013 Dec 13;288(50):35769-80
pubmed: 24174532
J Biomol Screen. 2011 Feb;16(2):174-82
pubmed: 21245471
Nat Rev Cancer. 2012 Apr 26;12(6):401-10
pubmed: 22534666
Anticancer Agents Med Chem. 2014;14(8):1169-78
pubmed: 24954859
Bioorg Med Chem. 2015 Jul 1;23(13):3237-47
pubmed: 25979376

Auteurs

Yuanyuan Fu (Y)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Liang Hong (L)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Jiecheng Xu (J)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Guoping Zhong (G)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Qiong Gu (Q)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Qianqian Gu (Q)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Yanping Guan (Y)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Xueping Zheng (X)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Qi Dai (Q)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Xia Luo (X)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Cui Liu (C)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Zhiying Huang (Z)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Xiao-Ming Yin (XM)

b Department of Pathology and Laboratory Medicine , Indiana University School of Medicine , Indianapolis , IN , USA.

Peiqing Liu (P)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Min Li (M)

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH